Breast (Mar 2023)

P126 Pathological complete response after neoadjuvant chemotherapy in patients with HER2 low and HER2 0 early breast cancer (eBC) – experience from Institute for Oncology and Radiology of Serbia (IORS)

  • O. Djurmez,
  • M. Calamac,
  • N. Stanic,
  • M. Dimitrijevic,
  • J. Vukosavljevic,
  • K. Serovic,
  • J. Oblakovic-Babic,
  • I. Minic,
  • D. Gavrilovic,
  • I. Bozovic-Spasojevic

Journal volume & issue
Vol. 68
p. S64

Abstract

Read online

No abstracts available.